Vivani Medical, Inc.

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Vivani leverages proprietary technologies to develop and commercialize drug and device implants, including its lead asset NPM-119 (exenatide implant), which seeks to treat patients with chronic diseases with high unmet medical need.

NASDAQ:VANI

Vivani Medical, Inc.

Last Close

1.25

26/07 20:00

Market Cap

68.72M

Beta: -

Volume Today

66.49K

Avg: 57.64K

PE Ratio

−1.97

PFCF: −2.02

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics